George Farmer
Stock Analyst at Scotiabank
(2.75)
# 1,274
Out of 4,667 analysts
57
Total ratings
35.48%
Success rate
1.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by George Farmer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Upgrades: Sector Outperform | $439 → $715 | $591.82 | +20.81% | 5 | Nov 5, 2024 | |
| SAGE Sage Therapeutics | Maintains: Sector Outperform | $17 → $14 | $4.91 | +185.13% | 4 | Oct 30, 2024 | |
| AURA Aura Biosciences | Maintains: Sector Outperform | $20 → $23 | $8.75 | +162.86% | 2 | Oct 18, 2024 | |
| SKYE Skye Bioscience | Initiates: Sector Outperform | $20 | $4.28 | +367.29% | 1 | Sep 30, 2024 | |
| BMEA Biomea Fusion | Maintains: Sector Outperform | $21 → $41 | $6.28 | +552.87% | 3 | Sep 27, 2024 | |
| BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $95 → $78 | $62.56 | +24.68% | 7 | Sep 17, 2024 | |
| INMB INmune Bio | Initiates: Sector Outperform | $22 | $4.56 | +382.46% | 1 | Aug 22, 2024 | |
| LEGN Legend Biotech | Maintains: Sector Outperform | $70 → $76 | $40.14 | +89.34% | 4 | Aug 12, 2024 | |
| JANX Janux Therapeutics | Maintains: Sector Perform | $47 → $42 | $48.96 | -14.22% | 2 | Aug 9, 2024 | |
| BIIB Biogen | Maintains: Sector Outperform | $275 → $244 | $156.00 | +56.41% | 2 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $3.15 | $0.66 | +373.90% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $2.68 | +385.07% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $35 | $20.01 | +74.91% | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $13 | $0.90 | +1,347.02% | 2 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $36 → $23 | $15.95 | +44.20% | 2 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $66 | $87.22 | -24.33% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Perform | $11 | $15.91 | -34.00% | 1 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $109 | $36.94 | +195.07% | 3 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $94 → $87 | $71.05 | +22.45% | 5 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $4.05 | +714.81% | 1 | Oct 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $1.07 | +3,638.32% | 1 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $27 | $34.65 | -22.08% | 3 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $75 | $94.81 | -20.89% | 3 | Apr 29, 2020 |
argenx SE
Nov 5, 2024
Upgrades: Sector Outperform
Price Target: $439 → $715
Current: $591.82
Upside: +20.81%
Sage Therapeutics
Oct 30, 2024
Maintains: Sector Outperform
Price Target: $17 → $14
Current: $4.91
Upside: +185.13%
Aura Biosciences
Oct 18, 2024
Maintains: Sector Outperform
Price Target: $20 → $23
Current: $8.75
Upside: +162.86%
Skye Bioscience
Sep 30, 2024
Initiates: Sector Outperform
Price Target: $20
Current: $4.28
Upside: +367.29%
Biomea Fusion
Sep 27, 2024
Maintains: Sector Outperform
Price Target: $21 → $41
Current: $6.28
Upside: +552.87%
BioMarin Pharmaceutical
Sep 17, 2024
Maintains: Sector Perform
Price Target: $95 → $78
Current: $62.56
Upside: +24.68%
INmune Bio
Aug 22, 2024
Initiates: Sector Outperform
Price Target: $22
Current: $4.56
Upside: +382.46%
Legend Biotech
Aug 12, 2024
Maintains: Sector Outperform
Price Target: $70 → $76
Current: $40.14
Upside: +89.34%
Janux Therapeutics
Aug 9, 2024
Maintains: Sector Perform
Price Target: $47 → $42
Current: $48.96
Upside: -14.22%
Biogen
Aug 2, 2024
Maintains: Sector Outperform
Price Target: $275 → $244
Current: $156.00
Upside: +56.41%
May 30, 2024
Initiates: Sector Outperform
Price Target: $3.15
Current: $0.66
Upside: +373.90%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $2.68
Upside: +385.07%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $35
Current: $20.01
Upside: +74.91%
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $0.90
Upside: +1,347.02%
Jan 31, 2024
Downgrades: Sector Perform
Price Target: $36 → $23
Current: $15.95
Upside: +44.20%
Dec 19, 2023
Initiates: Sector Outperform
Price Target: $66
Current: $87.22
Upside: -24.33%
Jul 27, 2023
Initiates: Sector Perform
Price Target: $11
Current: $15.91
Upside: -34.00%
Nov 17, 2020
Downgrades: Market Perform
Price Target: $109
Current: $36.94
Upside: +195.07%
Nov 6, 2020
Maintains: Market Perform
Price Target: $94 → $87
Current: $71.05
Upside: +22.45%
Oct 27, 2020
Initiates: Outperform
Price Target: $33
Current: $4.05
Upside: +714.81%
Jul 20, 2020
Initiates: Outperform
Price Target: $40
Current: $1.07
Upside: +3,638.32%
May 6, 2020
Maintains: Market Perform
Price Target: $20 → $27
Current: $34.65
Upside: -22.08%
Apr 29, 2020
Maintains: Outperform
Price Target: $89 → $75
Current: $94.81
Upside: -20.89%